Drugs / Epoetin Alfa-BioSimilar
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01184495 Comparator | Apr → Dec 2008 | — | Hospital de Clinicas de Porto Alegre | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epoetin Alfa-BioSimilar | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01184495 ↗ |
| Modality | Protein / enzyme biologic | “a biosimilar epoetin formulation” PMID 25141114 ↗ Aug 2014 |
| Route | Subcutaneous | “Subcutaneous administration of EPO-BioSimilar” NCT01184495 ↗ |